Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v15-EN
Language English English
Date Updated 2018-07-17 2018-07-17
Drug Identification Number 02301334 02301334
Brand name BRIMONIDINE P BRIMONIDINE P
Common or Proper name Brimonidine P Brimonidine P
Company Name AA PHARMA INC AA PHARMA INC
Ingredients BRIMONIDINE TARTRATE BRIMONIDINE TARTRATE
Strength(s) 0.15% 0.15%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ml 10ml
ATC code S01EA S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-09 2018-02-09
Estimated end date 2018-07-18 2018-07-18
Actual end date 2018-07-16 2018-07-16
Shortage status Resolved Resolved
Company comments Brimonidine P 0.15% 5ml is available. Brimonidine P 0.15% 5ml is available.
Health Canada comments